Manuel D. Gahete

5.0k total citations
155 papers, 3.8k citations indexed

About

Manuel D. Gahete is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Manuel D. Gahete has authored 155 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 56 papers in Endocrinology, Diabetes and Metabolism and 50 papers in Epidemiology. Recurrent topics in Manuel D. Gahete's work include Growth Hormone and Insulin-like Growth Factors (39 papers), Neuroendocrine Tumor Research Advances (38 papers) and Pituitary Gland Disorders and Treatments (30 papers). Manuel D. Gahete is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (39 papers), Neuroendocrine Tumor Research Advances (38 papers) and Pituitary Gland Disorders and Treatments (30 papers). Manuel D. Gahete collaborates with scholars based in Spain, United States and Italy. Manuel D. Gahete's co-authors include Raúl M. Luque, Justo P. Castaño, Rhonda D. Kineman, José Córdoba‐Chacón, Francisco Gracia‐Navarro, Antonio J. Martínez‐Fuentes, Mario Durán‐Prado, Marı́a M. Malagón, Alejandro Ibáñez‐Costa and Antonio C. Fuentes-Fayos and has published in prestigious journals such as PLoS ONE, Brain and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Manuel D. Gahete

151 papers receiving 3.7k citations

Peers

Manuel D. Gahete
Bentley Cheatham United States
Weimin He China
Lisa Hahner United States
Jonathan S. Bogan United States
Manuel D. Gahete
Citations per year, relative to Manuel D. Gahete Manuel D. Gahete (= 1×) peers Raúl M. Luque

Countries citing papers authored by Manuel D. Gahete

Since Specialization
Citations

This map shows the geographic impact of Manuel D. Gahete's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel D. Gahete with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel D. Gahete more than expected).

Fields of papers citing papers by Manuel D. Gahete

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel D. Gahete. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel D. Gahete. The network helps show where Manuel D. Gahete may publish in the future.

Co-authorship network of co-authors of Manuel D. Gahete

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel D. Gahete. A scholar is included among the top collaborators of Manuel D. Gahete based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel D. Gahete. Manuel D. Gahete is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pardo, Virginia, Antonio C. Fuentes-Fayos, Juan Aranda, et al.. (2025). MiR-7 inhibits progression of glioblastoma by impairing autophagy resolution, energy metabolism and ECM remodeling. Journal of Experimental & Clinical Cancer Research. 44(1). 237–237.
2.
Bellido, M., et al.. (2025). Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma. Cellular and Molecular Life Sciences. 82(1). 173–173. 2 indexed citations
3.
Sarmento‐Cabral, André, Oriol Alberto Rangel-Zúñiga, Julia Carrasco‐Valiente, et al.. (2025). miR-191–5p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesity. Biomedicine & Pharmacotherapy. 189. 118330–118330.
4.
Alors‐Pérez, Emilia, Marina Sánchez‐Frías, Andrea Mafficini, et al.. (2024). The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma. Cancer Gene Therapy. 31(11). 1646–1657. 2 indexed citations
5.
Yubero‐Serrano, Elena M., Laura M. López‐Sánchez, Sara Romero-Martín, et al.. (2024). The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer. Cellular and Molecular Life Sciences. 82(1). 18–18. 1 indexed citations
6.
Herrera‐Martínez, Aura D., Antonio C. Fuentes-Fayos, André Sarmento‐Cabral, et al.. (2024). Does Telotristat Have a Role in Preventing Carcinoid Heart Disease?. International Journal of Molecular Sciences. 25(4). 2036–2036. 1 indexed citations
7.
Herrera‐Martínez, Aura D., Antonio Casado‐Díaz, María Ángeles Gálvez-Moreno, et al.. (2023). Bariatric surgery and calcifediol treatment, Gordian knot of severe-obesity-related comorbidities treatment. Frontiers in Endocrinology. 14. 1243906–1243906. 2 indexed citations
8.
Rosa, I. Arias de la, C. Pérez‐Sánchez, Fernando Leiva‐Cepas, et al.. (2023). Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis. European Journal of Internal Medicine. 118. 49–58. 13 indexed citations
9.
Amaro‐Gahete, Francisco J., Andrea Jiménez, Francisco J. Osuna‐Prieto, et al.. (2022). Multidisciplinary Prehabilitation and Postoperative Rehabilitation for Avoiding Complications in Patients Undergoing Resection of Colon Cancer: Rationale, Design, and Methodology of the ONCOFIT Study. Nutrients. 14(21). 4647–4647. 13 indexed citations
10.
Pedraza‐Arévalo, Sergio, Emilia Alors‐Pérez, Aura D. Herrera‐Martínez, et al.. (2022). Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors. Translational research. 251. 63–73. 12 indexed citations
11.
12.
Fuentes-Fayos, Antonio C., Mari C. Vázquez‐Borrego, Juan M. Jiménez‐Vacas, et al.. (2020). Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3. Brain. 143(11). 3273–3293. 56 indexed citations
13.
Río-Moreno, Mercedes del, Raúl M. Luque, Oriol Alberto Rangel-Zúñiga, et al.. (2020). Dietary Intervention Modulates the Expression of Splicing Machinery in Cardiovascular Patients at High Risk of Type 2 Diabetes Development: From the CORDIOPREV Study. Nutrients. 12(11). 3528–3528. 9 indexed citations
14.
Sarmento‐Cabral, André, Fernando L‐López, Manuel D. Gahete, Justo P. Castaño, & Raúl M. Luque. (2017). Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways. Molecular Cancer Research. 15(7). 862–874. 31 indexed citations
15.
Herrera‐Martínez, Aura D., Manuel D. Gahete, Sergio Pedraza‐Arévalo, et al.. (2017). Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors. Endocrine. 59(2). 426–437. 28 indexed citations
16.
Hormaechea‐Agulla, Daniel, Manuel D. Gahete, Juan M. Jiménez‐Vacas, et al.. (2017). The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness. Molecular Cancer. 16(1). 146–146. 38 indexed citations
17.
Lubbers, Ellen R., Edward O. List, Adam Jara, et al.. (2012). Adiponectin in mice with altered GH action: links to insulin sensitivity and longevity?. Journal of Endocrinology. 216(3). 363–374. 42 indexed citations
18.
Córdoba‐Chacón, José, et al.. (2012). Role of Endogenous Somatostatin and Cortistatin in Regulating Adrenal Gland Function. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations
19.
Luque, Raúl M., José Córdoba‐Chacón, Manuel D. Gahete, et al.. (2011). Kisspeptin Regulates Gonadotroph and Somatotroph Function in Nonhuman Primate Pituitary via Common and Distinct Signaling Mechanisms. Endocrinology. 152(3). 957–966. 81 indexed citations
20.
Córdoba‐Chacón, José, Raúl M. Luque, Manuel D. Gahete, et al.. (2008). Identification and molecular characterization of new somatostatin receptor subtype 5 truncated isoforms in rodents. 16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026